前收市價 | 1.2100 |
開市 | 1.1900 |
買盤 | 1.1700 x 100 |
賣出價 | 1.2300 x 100 |
今日波幅 | 1.1900 - 1.2125 |
52 週波幅 | 0.3600 - 6.6000 |
成交量 | |
平均成交量 | 78,452 |
市值 | 19.257M |
Beta 值 (5 年,每月) | 1.42 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -7.5800 |
業績公佈日 | 2024年5月06日 - 2024年5月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 12.00 |
Aptose Biosciences (APTO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript March 26, 2024 Aptose Biosciences Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Jonathan and I will be your conference operator today. I would like […]
Assertio (ASRT) appears weighed down by the recent leadership transition. The company is also facing challenges with sales of its product franchisee of late.